Section 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Section 2: EXECUTIVE SUMMARY
2.1. CXO perspective
Section 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Market dynamics
3.3.1. Drivers
3.3.1.1. Increase in incidence of chronic diseases
3.3.1.2. High focus on early diagnosis of diseases
3.3.2. Restraint
3.3.2.1. Shortage of pathologists
3.3.3. Opportunity
3.3.3.1. Use of digital pathology in disease diagnosis
Section 4: GLOBAL PATHOLOGICAL EXAMINATION MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Digestive organs
4.2.1. Key market trends, growth factors, and opportunities
4.3. Other Applications
4.3.1. Key market trends, growth factors, and opportunities
Section 5: PATHOLOGICAL EXAMINATION MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Traditional Pathology
5.2.1. Key market trends, growth factors, and opportunities
5.3. Digital Pathology
5.3.1. Key market trends, growth factors, and opportunities
Section 6: PATHOLOGICAL EXAMINATION MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. U.S.
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by application
6.2.3. Market size and forecast, by type
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by application
6.3.3. Market size and forecast, by type
6.4. Asia
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by application
6.4.3. Market size and forecast, by type
6.5. ROW
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by application
6.5.3. Market size and forecast, by type